LMO (Luxembourg & UK) and In-Space Missions Ltd (UK) have partnered to explore the use of small satellite platforms for space-based Space Domain Awareness (SDA) as part of LMO’s AUREA (Autonomous
New funding will support the rapid growth of Aphea.Bio, solidifying its position as a frontrunner in biological product development for agriculture.
Gent, Belgium, 11 July 2023 – Aphea.Bio, a
LMO a dual-use space company focused on space domain awareness, space surveillance and in-orbit servicing has successfully deployed and validated in space a first of a kind autonomous on-orbit
Mont-Saint-Guibert, 9 th May 2023 – VOCSens unveils EnviCam® -30, its 1 st generation of multi-gas microsensor addressing the request for actionable gas concentration data in Smart Building, Chemical
March 09th, Namur - Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding. The successful fundraising is led by Kurma Partners and includes the exceptional entry
Cellaion SA announces a total fundraising of EUR 23 million in 2022 for its phase IIB study in Acute on Chronic Liver Failure with Truffle Capital as lead investor in the final Closing followed by
MONT SAINT-GUIBERT, BELGIUM – December 8, 2022 – Novadip Biosciences SA (“Novadip” or “the Company”), a clinical-stage biopharmaceutical company developing a new class of regenerative tissue products
Funding will support development of next generation orthopedic products that provide accelerated healing through single treatment cures
Mont Saint-Guibert, Belgium – November 3, 2022 – Novadip
Botalys aims to become the world leader in hydroponic precision farming of medicinal plants thanks to its revolutionary technological platform.
Belgian company Botalys, a world pioneer in the
A major turning point for people at risk of cardiovascular disease, obesity and diabetes.
Mont-Saint-Guibert, June 29, 2022
- A crucial step has been taken by the Belgian company The Akkermansia
LEUVEN, Belgium, June 16th, 2022 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that